I am a physician and scientist, my friends are successful business men and I am getting tired of having to re-explain everything and why the PR is actually incredibly important and data is unusually impressive. We are treating patients with remdesivir, dexamethasone and other supportive care measures. We have no other FDA approved therapeutics new since the pandemic started. We are the first company since GlLD that I am aware of that has completed a P2 trial and reported statistically significant results in the treatment versus placebo arm in a double blind RCT. THIS IS HUGE. Yet the market yawns and scratches their head again at the PR this morning.